DHG Pharmaceutical JSC (HOSE:DHG)

Market Cap	13.22T
Revenue (ttm)	4.88T
Net Income (ttm)	753.55B
Shares Out	130.75M
EPS (ttm)	5,763.48
PE Ratio	17.54
Forward PE	n/a
Dividend	7,500.00 (7.42%)
Ex-Dividend Date	Dec 24, 2024

Volume	30,700
Average Volume	25,745
Open	101,100
Previous Close	101,100
Day's Range	101,000 - 101,600
52-Week Range	96,500 - 125,900
Beta	0.57
RSI	44.88
Earnings Date	Apr 18, 2025

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in dietary supplements and pharmaceuticals cosmetics. The company exports its products to approximately 20 countries. The company was founded...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,806
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.